CollPlant Biotechnologies annual free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Free Cash Flow (FCF) History (CLGN)
CollPlant Biotechnologies reported −$9.4M in free cash flow for fiscal 2025, an increase of $5.1M from the previous fiscal year, with a free cash flow margin of −398.44%.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$9.4M | $5.1M | — | −398.44% |
| 2024 | 2024-12-31 | −$14.6M | −$10.9M | — | −2830.29% |
| 2023 | 2023-12-31 | −$3.7M | $11.3M | — | −33.92% |
| 2022 | 2022-12-31 | −$15.0M | −$16.0M | — | −5007.36% |
| 2021 | 2021-12-31 | $1.1M | $6.0M | — | +6.86% |
| 2020 | 2020-12-31 | −$4.9M | $2.3M | — | −79.65% |
| 2019 | 2019-12-31 | −$7.2M | −$5.1M | — | −310.35% |
| 2018 | 2018-12-31 | −$2.0M | $3.0M | — | −40.87% |
| 2017 | 2017-12-31 | −$5.1M | — | — | −1100.00% |
CollPlant Biotechnologies quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
CollPlant Biotechnologies free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$4.9M to −$9.4M, a net decrease of $4.6M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review CollPlant Biotechnologies filings at SEC.gov ↗